Full Press Release Details
Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia.
IONS
Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia
Key Takeaway: Ionis initiates pivotal Phase 3 clinical study of olezarsen in patients with severe hypertriglyceridemia